Results 201 to 210 of about 85,655 (308)

Mycosis fungoides and Sézary syndrome. [PDF]

Br J Haematol
Martins F, Calvão J.
europepmc   +1 more source

Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridization [PDF]

, 1993
Cremer, Thomas, Knuutila, Sakari, Popp, Susanne, Ruutu, Tapani, Volin, L., Wessman, M.   +5 more
core  

Granuloma annulare: not as simple as it seems. [PDF]

, 2010
Parish, Lawrence Charles, Witkowski, Joseph A.   +1 more
core   +1 more source

Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs

Veterinary Dermatology, EarlyView.
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain, Andrew Lowe, Elizabeth A. Mauldin   +2 more
wiley   +1 more source

Extranodal Natural Killer (NK)/T-Cell Lymphoma Causing Severe Facial Destruction Refractory to Chemotherapy and Immunotherapy. [PDF]

Cureus
Tiu RA, Garcia JF.
europepmc   +1 more source

Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study

Veterinary Dermatology, EarlyView.
Lapatinib is widely used in human oncology; however, dermatological adverse events (DAEs) are common and have been correlated with treatment efficacy. In veterinary medicine, lapatinib use in combination with piroxicam has been shown to be effective in treating canine urothelial carcinoma (UC); however, the incidence and prognostic significance of DAEs
Kosuke Horita, Tomohiro Yonezawa, Yasuyuki Momoi, Shingo Maeda   +3 more
wiley   +1 more source

Incidence of Hodgkin and Non-Hodgkin Lymphomas: Comparison of the Military and General Population. [PDF]

Cancer Med
Robins KR, Bytnar JA, DeStefano CB, Shriver CD, Zhu K.   +4 more
europepmc   +1 more source

Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms [PDF]

, 2009
Megan S. Lim, Laurence de Leval, Leticia Quintanilla-Martinez   +2 more
core   +1 more source

Cancer heterogeneity explored through immune cell deconvolution of the tumor microenvironment

Quantitative Biology, Volume 14, Issue 3, September 2026.
Abstract Cancer is a highly heterogeneous disease, characterized by significant variability across multiple dimensions. This diversity has been extensively studied from various perspectives. In this study, we aim to examine cancer heterogeneity through the lens of immune cell composition within the tumor microenvironment.
Limin Jiang, Chung‐I Li, Rui Xin, Jijun Tang, Yan Guo   +4 more
wiley   +1 more source

Aggressive GATA-3 Positive Primary Cutaneous Peripheral T-Cell Lymphoma - Not Otherwise Specified Masquerading as CD-4 Positive Small/Medium T-Cell Lymphoproliferative Disorder: Where is the Line of Delineation?

Indian J Dermatol
Kapetanovic I, Bosic M, Zivanovic D.
europepmc   +1 more source